CashuAlterity Therapeutics: Key Developments and Future Prospects in Neurodegenerative Disease Research2 days ago
CashuAlterity Therapeutics Advances PBT434 for Neurodegenerative Diseases: Promising Phase 2 Results4 days ago
CashuAlterity Therapeutics Advances PBT2 for Neurodegenerative Diseases, Enhancing Cognitive Function6 days ago